Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
PDGFR
>>
Phase 4
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
97
194
291
388
485
582
679
776
873
970
sorafenib
/ Generic mfg.
imatinib
/ Generic mfg.
Focus V
(anlotinib) / Advenchen, Sino Biopharm
sunitinib
/ Generic mfg.
Lenvima
(lenvatinib) / Eisai, Merck (MSD)
dasatinib
/ Generic mfg.
Stivarga
(regorafenib) / Bayer
Votrient
(pazopanib) / Novartis, BeiGene
Tasigna
(nilotinib) / Novartis, Inhibikase
nintedanib
/ Generic mfg.
Iclusig
(ponatinib) / Takeda, Otsuka
Zepsun
(donafenib) / Suzhou Zelgen
Ayvakit
(avapritinib) / Blueprint Medicines
Gavreto
(pralsetinib) / Rigel
